XML 38 R22.htm IDEA: XBRL DOCUMENT v3.22.1
SHAREHOLDERS' EQUITY
12 Months Ended
Jan. 29, 2022
SHAREHOLDERS' EQUITY  
SHAREHOLDERS' EQUITY

14.   SHAREHOLDERS’ EQUITY

Stock Repurchase Programs

On December 14, 2018 and September 2, 2019, the Board of Directors approved stock repurchase programs (“2018 Program" and "2019 Program", respectively) authorizing the repurchase of the Company’s outstanding common stock of up to 2.5 million shares in the 2018 Program and 5.0 million shares in the 2019 Program.  The Company can use the repurchase programs to repurchase shares on the open market or in private transactions from time to time, depending on market conditions.  The repurchase programs do not have an expiration date.  Repurchases of common stock are limited

under the Company’s debt agreements.  In total, 2.5 million shares have been repurchased under the 2018 Program and there are no additional shares authorized to be repurchased.  During 2021, the Company repurchased 661,265 shares under the 2019 Program.  There are 1,990,224 additional shares authorized to be repurchased under the 2019 Program as of January 29, 2022.  Subsequent to year-end, the Board of Directors authorized an additional 7,000,000 shares under the Company’s stock repurchase programs.  With this increase, the Company has 8,990,224 shares authorized to be repurchased under the repurchase programs.    

Repurchases Related to Employee Share-based Awards

During 2021, 2020 and 2019, employees tendered 205,213, 160,101 and 100,728 shares, respectively, related to certain share-based awards.  These shares were tendered in satisfaction of the exercise price of stock options and/or to satisfy tax withholding amounts for non-qualified stock options, restricted stock and stock performance awards.  Accordingly, these share repurchases are not considered a part of the Company’s publicly announced stock repurchase programs.

Accumulated Other Comprehensive Loss

The following table sets forth the changes in accumulated other comprehensive loss, net of tax, by component for 2021, 2020 and 2019:

    

    

Pension and

    

    

Accumulated

Foreign

Other

Other

Currency

Postretirement

Derivative

Comprehensive

($ thousands)

Translation

Transactions (1)

Transactions (2)

(Loss) Income

Balance February 2, 2019

$

62

$

(31,055)

$

(608)

$

(31,601)

Other comprehensive (loss) income before reclassifications

 

(642)

 

(3,523)

 

315

 

(3,850)

Reclassifications:

 

  

 

  

 

  

 

  

Amounts reclassified from accumulated other comprehensive loss

 

 

4,590

 

256

 

4,846

Tax benefit

 

 

(1,183)

 

(55)

 

(1,238)

Net reclassifications

 

 

3,407

 

201

 

3,608

Other comprehensive (loss) income

 

(642)

 

(116)

 

516

 

(242)

Balance February 1, 2020

$

(580)

$

(31,171)

$

(92)

$

(31,843)

Other comprehensive income before reclassifications

 

469

 

20,351

 

87

 

20,907

Reclassifications:

 

  

 

  

 

  

 

  

Amounts reclassified from accumulated other comprehensive loss

 

 

2,418

 

6

 

2,424

Tax benefit

 

 

(623)

 

(1)

 

(624)

Net reclassifications

 

 

1,795

 

5

 

1,800

Other comprehensive income

 

469

 

22,146

 

92

 

22,707

Balance January 30, 2021

$

(111)

$

(9,025)

$

$

(9,136)

Other comprehensive loss before reclassifications

 

(677)

 

(116)

 

 

(793)

Reclassifications:

 

  

 

  

 

  

 

  

Amounts reclassified from accumulated other comprehensive loss

 

 

1,788

 

 

1,788

Tax benefit

 

 

(465)

 

 

(465)

Net reclassifications

 

 

1,323

 

 

1,323

Other comprehensive (loss) income

 

(677)

 

1,207

 

 

530

Balance January 29, 2022

$

(788)

$

(7,818)

$

$

(8,606)

(1)Amounts reclassified are included in other income, net.  Refer to Note 5 to the consolidated financial statements for additional information related to pension and other postretirement benefits.
(2)Amounts reclassified are included in net sales, costs of goods sold and selling and administrative expenses.  Refer to Note 1 to the consolidated financial statements for additional information related to derivative financial instruments.